Wht is GBS

Reading File
Finding Sources
Searching Images

Guillain-Barre syndrome nerve pathology ascending paralysis

This composite diagnostic image showcases MRI findings associated with Guillain-Barré syndrome (GBS) in a pediatric patient. Figure (a) is a sagittal T2-weighted MRI of the thoracolumbar spine, demonstrating a subtle, localized area of increased signal intensity (hyperintensity) at the level of the conus medullaris (indicated by an arrow). Figure (b) provides an axial T1-weighted post-contrast MRI of the lumbar spine, revealing prominent enhancement of multiple nerve roots within the cauda equina (indicated by multiple arrows). These visual features correlate with the typical inflammatory and autoimmune pathophysiology of GBS, which affects the peripheral nervous system and nerve roots. The presence of nerve root enhancement on post-contrast imaging is a key diagnostic indicator in clinical neurology. The images serve to illustrate how MRI can support the diagnosis of GBS by identifying involvement of the lower spinal cord and emerging nerve roots in patients presenting with progressive ascending weakness or paralysis.

This composite diagnostic image showcases MRI findings associated with Guillain-Barré syndrome (GBS) in a pediatric patient. Figure (a) is a sagittal T2-weighted MRI of the thoracolumbar spine, demonstrating a subtle, localized area of increased signal intensity (hyperintensity) at the level of the conus medullaris (indicated by an arrow). Figure (b) provides an axial T1-weighted post-contrast MRI of the lumbar spine, revealing prominent enhancement of multiple nerve roots within the cauda equina (indicated by multiple arrows). These visual features correlate with the typical inflammatory and autoimmune pathophysiology of GBS, which affects the peripheral nervous system and nerve roots. The presence of nerve root enhancement on post-contrast imaging is a key diagnostic indicator in clinical neurology. The images serve to illustrate how MRI can support the diagnosis of GBS by identifying involvement of the lower spinal cord and emerging nerve roots in patients presenting with progressive ascending weakness or paralysis.

Clinical photograph presenting a side-by-side comparison (Panel A and Panel B) of a patient with facial diplegia associated with Guillain-Barré syndrome. Panel A shows the patient at admission, exhibiting bilateral peripheral facial paralysis. Key clinical signs include lagophthalmos and Bell’s phenomenon, characterized by the inability to close the eyelids and the upward rotation of the eyeballs when attempting closure. There is a lack of animation and significant periorbital strain. Panel B demonstrates clinical resolution one month after presentation and treatment. There is a marked improvement in orbicularis oculi muscle function, as evidenced by the patient's ability to partially close the eyelids and a more relaxed facial expression with reduced periorbital edema. The comparison illustrates the classic presentation and recovery phase of bilateral seventh cranial nerve (facial nerve) involvement in an inflammatory demyelinating polyneuropathy scenario.

Clinical photograph presenting a side-by-side comparison (Panel A and Panel B) of a patient with facial diplegia associated with Guillain-Barré syndrome. Panel A shows the patient at admission, exhibiting bilateral peripheral facial paralysis. Key clinical signs include lagophthalmos and Bell’s phenomenon, characterized by the inability to close the eyelids and the upward rotation of the eyeballs when attempting closure. There is a lack of animation and significant periorbital strain. Panel B demonstrates clinical resolution one month after presentation and treatment. There is a marked improvement in orbicularis oculi muscle function, as evidenced by the patient's ability to partially close the eyelids and a more relaxed facial expression with reduced periorbital edema. The comparison illustrates the classic presentation and recovery phase of bilateral seventh cranial nerve (facial nerve) involvement in an inflammatory demyelinating polyneuropathy scenario.

This composite diagnostic image features Magnetic Resonance Imaging (MRI) of the thoracolumbar spinal cord in a pediatric patient diagnosed with Guillain-Barré syndrome. Panel (a) is a sagittal T1-weighted contrast-enhanced MRI showing prominent enhancement of the anterior caudal nerve roots, which appear hyperintense (bright) against the relatively darker spinal cord and cerebrospinal fluid. Panel (b) presents a digital subtraction image of the sagittal T1 sequence, which minimizes background anatomical signal to highlight the contrast uptake in the ventral roots (indicated by arrows). Panel (c) is a transverse T1-weighted contrast-enhanced section demonstrating localized enhancement specifically within the anterior motor nerve roots. These radiological findings illustrate the classic breakdown of the blood-nerve barrier and inflammatory changes characteristic of acute inflammatory demyelinating polyradiculoneuropathy. Key educational features include the anatomical localization of root involvement and the utility of contrast-enhanced sequences and subtraction techniques in differentiating inflammatory neuropathies from other causes of acute flaccid paralysis.

This composite diagnostic image features Magnetic Resonance Imaging (MRI) of the thoracolumbar spinal cord in a pediatric patient diagnosed with Guillain-Barré syndrome. Panel (a) is a sagittal T1-weighted contrast-enhanced MRI showing prominent enhancement of the anterior caudal nerve roots, which appear hyperintense (bright) against the relatively darker spinal cord and cerebrospinal fluid. Panel (b) presents a digital subtraction image of the sagittal T1 sequence, which minimizes background anatomical signal to highlight the contrast uptake in the ventral roots (indicated by arrows). Panel (c) is a transverse T1-weighted contrast-enhanced section demonstrating localized enhancement specifically within the anterior motor nerve roots. These radiological findings illustrate the classic breakdown of the blood-nerve barrier and inflammatory changes characteristic of acute inflammatory demyelinating polyradiculoneuropathy. Key educational features include the anatomical localization of root involvement and the utility of contrast-enhanced sequences and subtraction techniques in differentiating inflammatory neuropathies from other causes of acute flaccid paralysis.

Reading File
Reading File

Guillain-Barré Syndrome (GBS)

Definition

GBS is an acute inflammatory demyelinating polyneuropathy that results in rapidly progressive ascending weakness. It is one of the most common life-threatening diseases of the peripheral nervous system. Symptoms typically progress over ~2 weeks, reaching the nadir (lowest point) by 4 weeks from onset.
  • Robbins & Kumar Basic Pathology, p. 809
  • Bradley and Daroff's Neurology in Clinical Practice, p. 2663

Pathophysiology

  • Approximately two-thirds of cases are triggered by a preceding infection
  • The infection provokes microbe-specific T cells and antibodies that cross-react with nerve sheath antigens (molecular mimicry)
  • Both T-cell-mediated and antibody-mediated responses are involved; T cells are believed to play the dominant role
  • Injury is most extensive in nerve roots and proximal nerve segments, with mononuclear cell infiltrates rich in macrophages
  • The classic form is multifocal inflammatory demyelination of spinal roots and peripheral nerves, producing conduction blocks and reduced velocities

Triggers / Associated Pathogens

PathogenType
Campylobacter jejuniBacterium (most common)
Epstein-Barr virus (EBV)Virus
Cytomegalovirus (CMV)Virus
HIVVirus
Zika virusVirus
SARS-CoV-2Virus

Subtypes

SubtypeFeatures
AIDP (Acute Inflammatory Demyelinating Polyradiculoneuropathy)Most common in Europe & North America; demyelinating
AMAN (Acute Motor Axonal Neuropathy)Pure motor axonal; common in China; summer epidemics in children
AMSAN (Acute Motor-Sensory Axonal Neuropathy)Both motor + sensory axons; severe with poor recovery
Miller-Fisher Syndrome (MFS)Ophthalmoplegia, ataxia, areflexia; 6% of cases in the West; up to 18% in Taiwan

Diagnostic Criteria

Required:
  • Progressive weakness of both legs and arms
  • Areflexia or hyporeflexia
Supportive clinical features:
  • Progression over days to 4 weeks
  • Relative symmetry of symptoms
  • Mild sensory symptoms or signs
  • Bifacial palsies
  • Autonomic dysfunction
  • Absence of fever at onset
  • Recovery beginning 2-4 weeks after progression stops
Lab/Investigations:
  • CSF: Elevated protein with <10 cells/μL (albuminocytological dissociation)
  • Electrodiagnostics: Nerve conduction slowing or block

Clinical Features (Classic Presentation)

  1. Ascending weakness - starts in legs, moves upward
  2. Areflexia - loss of deep tendon reflexes
  3. Sensory changes - paresthesias, mild sensory loss
  4. Autonomic dysfunction - BP fluctuations, arrhythmias, urinary retention
  5. Respiratory failure - in severe cases (~30%), requiring mechanical ventilation
  6. Cranial nerve involvement - facial diplegia (7th nerve most common), bulbar palsy

MRI Findings

GBS can show nerve root enhancement on contrast MRI:
MRI showing cauda equina nerve root enhancement in GBS
MRI: cauda equina nerve root enhancement in GBS
Enhancement of the anterior motor nerve roots in the cauda equina is a key radiological finding, reflecting breakdown of the blood-nerve barrier:
GBS MRI - cauda equina root enhancement
GBS spinal MRI nerve root enhancement

Facial Diplegia in GBS

Bilateral facial nerve (VII) palsy with lagophthalmos and Bell's phenomenon is a characteristic cranial nerve manifestation:
GBS facial diplegia - bilateral facial nerve palsy at admission and recovery

Treatment

TreatmentMechanism
IVIG (intravenous immunoglobulin)Suppresses immune responses (exact mechanism unclear)
PlasmapheresisRemoves offending antibodies
Supportive careMechanical ventilation, physiotherapy, DVT prophylaxis
Note: Steroids are NOT effective in GBS and are not recommended.

Prognosis

  • Mortality dropped from ~33% (before positive-pressure ventilation) to currently 1-5%
  • Most patients who survive the acute phase recover with time
  • Recovery typically begins 2-4 weeks after progression stops
  • AMSAN subtype has the worst prognosis

Distinguishing GBS from CIDP

FeatureGBSCIDP
CourseAcute (<4 weeks)Chronic (>2 months)
PatternMonophasicRelapsing-remitting or progressive
TriggersOften post-infectiousOften idiopathic
TreatmentIVIG/plasmapheresisLong-term steroids + IVIG

Wht is GBS Anatomy and Physiology and signs and symptoms

Finding Sources
Finding Sources
Searching Images

peripheral nerve anatomy myelin sheath axon structure diagram

Two high-magnification transmission electron microscopy (TEM) micrographs depicting cross-sections of the femoral nerve showing advanced degenerative changes in the myelin sheath. The images demonstrate significant myelin disorganization and pathological vacuolization, highlighted by red arrows. In the left panel, the myelin sheath surrounding the axon appears thickened and fragmented, with loss of the normal compact lamellar structure. The right panel provides a closer view of focal vacuolization, where the myelin layers have separated to form clear, empty intra-myelinic spaces. These structural alterations represent demyelinating processes and nerve fiber degradation. Scale bars are provided at 1 μm. This visual content is used for neuropathology studies to illustrate pharmacological or traumatic effects on peripheral nerve integrity, specifically focusing on myelin sheath morphology and axon-myelin relationship.

Two high-magnification transmission electron microscopy (TEM) micrographs depicting cross-sections of the femoral nerve showing advanced degenerative changes in the myelin sheath. The images demonstrate significant myelin disorganization and pathological vacuolization, highlighted by red arrows. In the left panel, the myelin sheath surrounding the axon appears thickened and fragmented, with loss of the normal compact lamellar structure. The right panel provides a closer view of focal vacuolization, where the myelin layers have separated to form clear, empty intra-myelinic spaces. These structural alterations represent demyelinating processes and nerve fiber degradation. Scale bars are provided at 1 μm. This visual content is used for neuropathology studies to illustrate pharmacological or traumatic effects on peripheral nerve integrity, specifically focusing on myelin sheath morphology and axon-myelin relationship.

This pathophysiology diagram illustrates the cellular and molecular pathogenesis of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Guillain-Barr� syndrome (GBS). The central focus is a peripheral nerve fiber consisting of a yellow central axon enveloped by a green myelin sheath. The diagram is divided into two mechanistic pathways originating from a central leukocyte. On the left, the 'Autoimmunity (CIDP)' pathway depicts antibodies directly targeting the paranodal and nodal proteins Neurofascin-155 (NF155) and Contactin-1 on the myelin surface. On the right, the 'Molecular mimicry (GBS)' pathway shows a C. jejuni bacterium with lipooligosaccharides (LOS) that trigger the production of cross-reactive antibodies. These antibodies are shown binding to GM-1 gangliosides located on the myelin sheath. Small 'Y'-shaped icons represent antibodies throughout the diagram, illustrating the humoral immune response against neural components. The visual highlights the distinction between direct autoimmune targeting in CIDP and the infection-triggered molecular mimicry characteristic of GBS, both resulting in demyelination and nerve damage.

This pathophysiology diagram illustrates the cellular and molecular pathogenesis of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Guillain-Barr syndrome (GBS). The central focus is a peripheral nerve fiber consisting of a yellow central axon enveloped by a green myelin sheath. The diagram is divided into two mechanistic pathways originating from a central leukocyte. On the left, the 'Autoimmunity (CIDP)' pathway depicts antibodies directly targeting the paranodal and nodal proteins Neurofascin-155 (NF155) and Contactin-1 on the myelin surface. On the right, the 'Molecular mimicry (GBS)' pathway shows a C. jejuni bacterium with lipooligosaccharides (LOS) that trigger the production of cross-reactive antibodies. These antibodies are shown binding to GM-1 gangliosides located on the myelin sheath. Small 'Y'-shaped icons represent antibodies throughout the diagram, illustrating the humoral immune response against neural components. The visual highlights the distinction between direct autoimmune targeting in CIDP and the infection-triggered molecular mimicry characteristic of GBS, both resulting in demyelination and nerve damage.

This composite educational graphic illustrates the normal internal architecture of a peripheral nerve across different imaging modalities. On the far left, an anatomical diagram depicts a transverse cross-section highlighting the nested hierarchy of nerve structures: the epineurium (outermost sheath), the perineurium (enclosing individual fascicles), and the endoneurium (surrounding internal axons/neurons, represented as orange dots). This structural organization creates a characteristic 'honeycomb pattern.' To the right, three clinical imaging panels correlate this anatomy: 1) High-Resolution Ultrasound (HRUS) shows the nerve as a speckled, hyperechoic structure relative to surrounding muscle. 2) T1-weighted MRI demonstrates the nerve with moderate signal intensity, where fascicular boundaries begin to emerge. 3) Proton Density Fat-Suppressed (PDFS) MRI provides the clearest visualization of the honeycomb architecture, showing hypointense 'dots' representing nerve fascicles surrounded by hyperintense signal from the interfascicular epineural fat. This comparison is essential for diagnosing peripheral neuropathies and identifying loss of normal fascicular patterns.

This composite educational graphic illustrates the normal internal architecture of a peripheral nerve across different imaging modalities. On the far left, an anatomical diagram depicts a transverse cross-section highlighting the nested hierarchy of nerve structures: the epineurium (outermost sheath), the perineurium (enclosing individual fascicles), and the endoneurium (surrounding internal axons/neurons, represented as orange dots). This structural organization creates a characteristic 'honeycomb pattern.' To the right, three clinical imaging panels correlate this anatomy: 1) High-Resolution Ultrasound (HRUS) shows the nerve as a speckled, hyperechoic structure relative to surrounding muscle. 2) T1-weighted MRI demonstrates the nerve with moderate signal intensity, where fascicular boundaries begin to emerge. 3) Proton Density Fat-Suppressed (PDFS) MRI provides the clearest visualization of the honeycomb architecture, showing hypointense 'dots' representing nerve fascicles surrounded by hyperintense signal from the interfascicular epineural fat. This comparison is essential for diagnosing peripheral neuropathies and identifying loss of normal fascicular patterns.

Finding Sources
Finding Sources
Reading File
Reading File
Searching Images

Guillain-Barre syndrome ascending paralysis clinical signs autonomic dysfunction

Clinical photograph presenting a side-by-side comparison (Panel A and Panel B) of a patient with facial diplegia associated with Guillain-Barré syndrome. Panel A shows the patient at admission, exhibiting bilateral peripheral facial paralysis. Key clinical signs include lagophthalmos and Bell’s phenomenon, characterized by the inability to close the eyelids and the upward rotation of the eyeballs when attempting closure. There is a lack of animation and significant periorbital strain. Panel B demonstrates clinical resolution one month after presentation and treatment. There is a marked improvement in orbicularis oculi muscle function, as evidenced by the patient's ability to partially close the eyelids and a more relaxed facial expression with reduced periorbital edema. The comparison illustrates the classic presentation and recovery phase of bilateral seventh cranial nerve (facial nerve) involvement in an inflammatory demyelinating polyneuropathy scenario.

Clinical photograph presenting a side-by-side comparison (Panel A and Panel B) of a patient with facial diplegia associated with Guillain-Barré syndrome. Panel A shows the patient at admission, exhibiting bilateral peripheral facial paralysis. Key clinical signs include lagophthalmos and Bell’s phenomenon, characterized by the inability to close the eyelids and the upward rotation of the eyeballs when attempting closure. There is a lack of animation and significant periorbital strain. Panel B demonstrates clinical resolution one month after presentation and treatment. There is a marked improvement in orbicularis oculi muscle function, as evidenced by the patient's ability to partially close the eyelids and a more relaxed facial expression with reduced periorbital edema. The comparison illustrates the classic presentation and recovery phase of bilateral seventh cranial nerve (facial nerve) involvement in an inflammatory demyelinating polyneuropathy scenario.

Clinical photograph of a patient in a supine position on a bed, illustrating long-term motor deficits following a case of Guillain-Barre syndrome (GBS). The patient exhibits significant limb weakness and impaired motor control, documented as Medical Research Council (MRC) grade 3 power in the upper extremities and grade 2 power in the lower extremities five years post-onset. The upper limbs are partially elevated with visible wrist drop and lack of coordinated hand extension, while the lower limbs are extended and flaccid. The image demonstrates the chronic sequelae of Landry's ascending paralysis and the limitations in functional recovery despite long-term rehabilitation. This visual serves as an educational reference for assessing chronic neuromuscular motor weakness, deep tendon reflex impairment, and the potential for persistent disability in severe GBS cases involving albuminocytological dissociation and axonal damage.

Clinical photograph of a patient in a supine position on a bed, illustrating long-term motor deficits following a case of Guillain-Barre syndrome (GBS). The patient exhibits significant limb weakness and impaired motor control, documented as Medical Research Council (MRC) grade 3 power in the upper extremities and grade 2 power in the lower extremities five years post-onset. The upper limbs are partially elevated with visible wrist drop and lack of coordinated hand extension, while the lower limbs are extended and flaccid. The image demonstrates the chronic sequelae of Landry's ascending paralysis and the limitations in functional recovery despite long-term rehabilitation. This visual serves as an educational reference for assessing chronic neuromuscular motor weakness, deep tendon reflex impairment, and the potential for persistent disability in severe GBS cases involving albuminocytological dissociation and axonal damage.

This clinical photograph shows a pediatric patient in a critical care setting demonstrating signs of bilateral peripheral facial paralysis. The patient is supine on a hospital bed, exhibiting lack of facial muscle tone and an inability to achieve full eyelid closure (lagophthalmos), which is managed by taping the eyelids shut to prevent corneal desiccation and abrasion. An orotracheal tube is placed and secured with white adhesive tape at the right corner of the mouth, indicating the need for mechanical ventilation or airway protection due to respiratory muscle weakness or neurological compromise. Monitoring cables are visible in the background, further characterizing the patient's intensive care requirements. The image serves as a clinical illustration of severe cranial nerve involvement in neuromuscular disorders such as Guillain-Barré syndrome (GBS), where bilateral facial nerve palsy can occur alongside ascending weakness or respiratory failure.

This clinical photograph shows a pediatric patient in a critical care setting demonstrating signs of bilateral peripheral facial paralysis. The patient is supine on a hospital bed, exhibiting lack of facial muscle tone and an inability to achieve full eyelid closure (lagophthalmos), which is managed by taping the eyelids shut to prevent corneal desiccation and abrasion. An orotracheal tube is placed and secured with white adhesive tape at the right corner of the mouth, indicating the need for mechanical ventilation or airway protection due to respiratory muscle weakness or neurological compromise. Monitoring cables are visible in the background, further characterizing the patient's intensive care requirements. The image serves as a clinical illustration of severe cranial nerve involvement in neuromuscular disorders such as Guillain-Barré syndrome (GBS), where bilateral facial nerve palsy can occur alongside ascending weakness or respiratory failure.

Reading File
Finding Sources
Now I have comprehensive content. Let me compile the full answer.

GBS: Anatomy, Physiology, and Signs & Symptoms


Part 1: Anatomy - Structures Affected in GBS

GBS is a disease of the peripheral nervous system (PNS). To understand it, you need to know what structures are targeted.

Normal Peripheral Nerve Anatomy

A peripheral nerve has a layered architecture:
Peripheral nerve anatomy - epineurium, perineurium, endoneurium, fascicles
LayerWhat it is
EpineuriumOutermost connective tissue sheath surrounding the whole nerve
PerineuriumSurrounds individual fascicles (bundles of nerve fibers)
EndoneuriumSurrounds individual axons within a fascicle
Myelin sheathLipid-protein insulation wrapped around the axon by Schwann cells
AxonThe actual conducting fiber carrying electrical signals
Node of RanvierGaps in the myelin sheath where saltatory conduction occurs

What GBS Attacks

In the most common form (AIDP), GBS targets the myelin sheath of peripheral nerves and spinal nerve roots - especially the anterior (motor) and posterior (sensory) roots at the spinal cord entry/exit zones. Injury is most extensive at:
  1. Spinal nerve roots (proximal segments)
  2. Mixed peripheral nerves (motor + sensory)
  3. Cranial nerves (in ~45-75% of cases)
  4. Autonomic ganglia and nerve fibers (in ~65%)

Part 2: Physiology - How GBS Damages Nerves

Normal Nerve Conduction

In a healthy myelinated nerve, the electrical signal (action potential) jumps rapidly from one Node of Ranvier to the next - called saltatory conduction. This is fast and energy-efficient.

What Goes Wrong in GBS: Molecular Mimicry

The pathophysiology diagram below shows the key mechanism:
GBS/CIDP pathogenesis diagram - molecular mimicry, C. jejuni, antibodies against GM1 gangliosides on myelin
Step-by-step mechanism:
  1. Preceding infection (e.g., Campylobacter jejuni) stimulates the immune system
  2. C. jejuni has lipooligosaccharides (LOS) on its surface that mimic gangliosides (GM1, GD1b, GQ1b) found on nerve myelin - this is molecular mimicry
  3. The body produces cross-reactive antibodies that attack myelin sheaths and/or axons
  4. T cells and macrophages infiltrate nerve roots and peripheral nerves, stripping myelin
  5. Loss of myelin causes conduction block and slowing - signals cannot travel efficiently
  6. In severe cases, the axons themselves are damaged (axonal subtypes: AMAN, AMSAN)

Myelin Damage Under Electron Microscopy

This is what the demyelinating process looks like at the cellular level:
TEM of peripheral nerve showing myelin vacuolization and degeneration in demyelinating neuropathy
  • The myelin layers fragment and separate, forming vacuoles
  • Normal compact lamellar structure is lost
  • Macrophages intrude between the axon and myelin sheath, especially at Nodes of Ranvier

Part 3: Signs and Symptoms

GBS classically presents in 3 phases:
  1. Progressive phase - worsening over days to 4 weeks
  2. Plateau phase - stable for days to weeks
  3. Recovery phase - begins 2-4 weeks after progression stops

A. Motor Symptoms (MOST PROMINENT)

SymptomDetails
Ascending weaknessStarts in both legs, spreads upward to arms, trunk, face
Flaccid paralysisLower motor neuron pattern (floppy, not spastic)
Proximal > distalOften affects thigh/hip muscles early
Severity rangeFrom mild difficulty walking to total quadriplegia
Respiratory failure9-30% of patients need mechanical ventilation
Bilateral facial weaknessIn 50% of patients - cannot close eyes, drooping face
Bulbar palsyDifficulty swallowing and speaking (lower cranial nerves)
OphthalmoplegiaExtraocular muscle weakness (especially in Miller-Fisher variant)
Goldman-Cecil Medicine, p. 2402: "The most common manifestation is leg weakness that progresses into the arms. Bilateral facial weakness occurs in 50% of patients."

B. Sensory Symptoms

SymptomDetails
ParesthesiasTingling, "pins and needles" - often first symptom, worse in hands/fingers
Sensory lossMild; mainly distal vibration sense impaired
PainPresent in ~70% during acute phase - back pain, limb pain, interscapular pain
Dysesthetic painBurning/tingling of limbs
Note: Sensory symptoms are present but motor weakness dominates - pure sensory loss is not a major feature.

C. Areflexia (Reflex Loss)

  • Loss of deep tendon reflexes (DTRs) is an invariable feature - present in virtually all patients
  • Knee jerks, ankle jerks, biceps/triceps reflexes all absent
  • May be absent early or initially only in the legs

D. Autonomic Dysfunction (65% of patients)

Because GBS also attacks autonomic nerve fibers, patients can have serious cardiovascular and visceral instability:
Autonomic SymptomMechanism
Sinus tachycardiaSympathetic overactivity
Bradycardia / Heart block / AsystoleExcessive vagal (parasympathetic) activity
Labile hypertension / Orthostatic hypotensionLoss of vascular tone regulation
TachyarrhythmiasSympathetic-parasympathetic imbalance
Urinary retentionAutonomic bladder dysfunction
Constipation / IleusGastrointestinal atony
Anhidrosis or excessive sweatingSudomotor dysfunction
ECG changesT-wave abnormalities, ST depression, QT prolongation
"Vagal spells" - sudden bradycardia or asystole triggered by tracheal suctioning - are a serious ICU hazard.
Bradley and Daroff's Neurology, p. 2663

E. Cranial Nerve Signs (45-75% of cases)

NerveSign
CN VII (Facial)Bilateral facial paresis - most common; lagophthalmos, inability to close eyes
CN III, IV, VIOphthalmoplegia (especially Miller-Fisher variant)
CN IX, XBulbar palsy - dysphagia, dysphonia
CN XI, XIILess common - neck/tongue weakness
Clinical photos showing bilateral facial nerve palsy (lagophthalmos, Bell's phenomenon) at admission and after recovery:
GBS facial diplegia - bilateral peripheral facial paralysis at admission vs 1 month recovery

F. In Severe/Prolonged Cases

Long-term motor deficits can persist in severe GBS, particularly with axonal subtypes (AMSAN):
Chronic GBS motor deficit - flaccid limbs, wrist drop, MRC grade 2-3 power years after onset

Summary Table of All Signs and Symptoms

CategoryFeatureFrequency
MotorAscending flaccid weakness~100%
MotorRespiratory failure9-30%
MotorBilateral facial palsy~50%
ReflexesAreflexia~100%
SensoryParesthesias (tingling)Common
SensoryPain (back/limb)~70%
SensorySensory lossMild, ~majority
AutonomicTachycardia/bradycardia~65%
AutonomicBP instability~65%
AutonomicUrinary retentionCommon
CranialFacial nerve palsy45-75%
CranialOphthalmoplegia (MFS)6% overall

Key Lab/Diagnostic Findings That Support the Anatomy

TestFindingAnatomical basis
CSFHigh protein, <10 WBC/mL ("albuminocytological dissociation")Protein leaks from inflamed nerve roots into CSF
Nerve conduction studiesSlowed velocity, conduction blocks, absent F-wavesDemyelination of peripheral nerves
MRI spine (contrast)Enhancement of cauda equina nerve rootsBreakdown of blood-nerve barrier at root level
EMGDenervation patterns in axonal subtypesMotor axon damage
Sources: Bradley and Daroff's Neurology in Clinical Practice; Goldman-Cecil Medicine; Robbins & Kumar Basic Pathology
This is a shared conversation. Sign in to Orris to start your own chat.